Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New osteoarthritis treatment candidate blocks cartilage degradation

Nov. 18, 1998

MK-966 improves physical ability and quality of life in patients with OA, RA

Nov. 18, 1998

Amgen evaluates novel TNF-targeted immunotherapy in patients with active RA

Nov. 17, 1998

Stromelysin inhibitor Bay-12-9566 enters clinical testing for a second indication

Nov. 17, 1998

TheraTech achieves targeted delivery of doxorubicin to inflammatory sites in mice with CIA

Nov. 16, 1998

Celecoxib studies continue to generate impressive efficacy and safety data

Nov. 16, 1998

Boston Life Sciences presents amiprilose phase III data at ACR meeting

Nov. 16, 1998

rHuIL-4 safe in patients with RA; efficacy studies are indicated

Nov. 16, 1998

Nonantimicrobial tetracycline exerts antiarthritic effects via upregulation of IL-10 production

Nov. 16, 1998

Hydroxamic acid compounds as inhibitors of TNF production and/or MMPs

Nov. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...